We previously found that JMJD6 is essential for the survival of neuroblastoma cells (including MYCN-amplified and MYC-overexpressed cells) (Yang et al., 2017), which was further validated by an independent study (Wong et al., 2019), indicating that neuroblastoma has JMJD6 dependency. The gene discussed is JMJD6; the disease is neuroblastoma.